You can find the annual or quarterly income statement of MoonLake Immunotherapeutics here for insights into the performance and operational efficiency of MoonLake Immunotherapeutics.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

Operating expenses

65.69%71.43M

98.50%60.70M

139.58%47.48M

229.90%49.58M

232.23%43.11M

131.90%30.58M

53.27%19.82M

-9.99%15.03M

-12.14%12.98M

-25.30%13.19M

-18.89%12.93M

16.94%16.70M

135.68%14.77M

-45.99%17.65M

--15.94M

--14.28M

--6.27M

--32.68M

R&D expenses

69.68%60.63M

110.30%49.76M

180.15%36.46M

398.40%40.36M

371.13%35.74M

171.86%23.66M

75.51%13.01M

-28.77%8.10M

-15.95%7.59M

-23.65%8.70M

-29.08%7.42M

127.72%11.37M

1247.88%9.02M

-61.83%11.40M

--10.45M

--4.99M

--669.53K

--29.87M

Depreciation, depletion, and amortization

2191.25%745.00K

2539.44%742.00K

1556.95%378.00K

39464.88%1.30M

888.30%32.52K

754.73%28.11K

593.40%22.81K

0.00%3.29K

-0.09%3.29K

0.03%3.29K

32.23%3.29K

32.25%3.29K

45.00%3.29K

--3.29K

--2.49K

--2.27K

----

Other operating expenses

----

--0.00

----

Operating profit

-65.69%-71.43M

-98.50%-60.70M

-139.58%-47.48M

-229.90%-49.58M

-232.23%-43.11M

-131.90%-30.58M

-53.27%-19.82M

9.99%-15.03M

12.14%-12.98M

25.30%-13.19M

18.89%-12.93M

-16.94%-16.70M

-135.68%-14.77M

45.99%-17.65M

---15.94M

---14.28M

---6.27M

---32.68M

Net non-operating interest income (expenses)

Non-operating interest expense

--3.20M

--2.04M

--18.00K

----

Other non-operating income (expenses)

-42.83%4.05M

14.93%6.78M

19.98%7.10M

-55.11%3.23M

411.41%7.09M

599.95%5.90M

717.48%5.92M

2900.28%7.19M

3587.69%1.39M

243.76%842.65K

941.05%723.59K

765.13%239.50K

280.39%37.59K

6584.92%245.13K

--69.51K

---36.01K

---20.84K

---3.78K

Income before tax

-95.93%-70.58M

-126.73%-55.96M

-190.58%-40.41M

-491.02%-46.35M

-210.79%-36.02M

-99.95%-24.68M

-13.90%-13.91M

52.34%-7.84M

21.33%-11.59M

29.09%-12.34M

23.09%-12.21M

-14.98%-16.46M

-134.30%-14.73M

46.74%-17.41M

---15.87M

---14.31M

---6.29M

---32.69M

Income tax

24.86%115.00K

20.71%95.00K

117.79%153.00K

-7.15%41.14K

218.45%92.11K

675.61%78.70K

538.07%70.25K

302.36%44.31K

230.93%28.92K

9.32%10.15K

50.16%11.01K

131.59%11.01K

--8.74K

--9.28K

--7.33K

--4.75K

--0.00

Income after tax

-95.75%-70.69M

-126.39%-56.05M

-190.21%-40.56M

-488.23%-46.40M

-210.81%-36.11M

-100.42%-24.76M

-14.38%-13.98M

52.10%-7.89M

21.18%-11.62M

29.07%-12.35M

23.05%-12.22M

-15.01%-16.47M

-134.44%-14.74M

46.72%-17.42M

---15.88M

---14.32M

---6.29M

---32.69M

Net income from continuous operations

-95.75%-70.69M

-126.39%-56.05M

-190.21%-40.56M

-488.23%-46.40M

-210.81%-36.11M

-100.42%-24.76M

-14.38%-13.98M

52.10%-7.89M

21.18%-11.62M

29.07%-12.35M

23.05%-12.22M

-15.01%-16.47M

-134.44%-14.74M

46.72%-17.42M

---15.88M

---14.32M

---6.29M

---32.69M

Other net gains and losses

----

---2.00

----

Net Income attributable to non-controlling interests

-33.27%-965.00K

-68.99%-831.00K

-103.73%-615.00K

-75.70%-791.19K

66.99%-724.09K

77.79%-491.74K

90.61%-301.87K

96.90%-450.31K

---2.19M

---2.21M

---3.21M

---14.53M

----

Net income attributable to controlling interests

-97.03%-69.73M

-127.55%-55.22M

-192.12%-39.94M

-513.20%-45.60M

-275.45%-35.39M

-139.34%-24.27M

-51.85%-13.67M

-284.32%-7.44M

36.06%-9.43M

41.78%-10.14M

43.29%-9.00M

86.48%-1.94M

-134.44%-14.74M

46.72%-17.42M

---15.88M

---14.32M

---6.29M

---32.69M

Net income attributable to common shareholders

-97.03%-69.73M

-127.55%-55.22M

-192.12%-39.94M

-513.20%-45.60M

-275.45%-35.39M

-139.34%-24.27M

-51.85%-13.67M

-284.32%-7.44M

36.06%-9.43M

41.78%-10.14M

43.29%-9.00M

86.48%-1.94M

-134.44%-14.74M

46.72%-17.42M

---15.88M

---14.32M

---6.29M

---32.69M

Basic earnings per share

-95.56%-1.10

-126.08%-0.87

-189.37%-0.63

-483.68%-0.72

-219.46%-0.56

-66.51%-0.39

5.31%-0.22

-155.79%-0.12

55.88%-0.18

53.15%-0.23

46.40%-0.23

87.51%-0.05

-134.44%-0.40

44.11%-0.49

---0.43

---0.39

---0.17

---0.89

Diluted earnings per share

-95.56%-1.10

-126.08%-0.87

-189.37%-0.63

-483.68%-0.72

-219.46%-0.56

-66.51%-0.39

5.31%-0.22

-155.79%-0.12

55.88%-0.18

53.15%-0.23

46.40%-0.23

87.51%-0.05

-134.44%-0.40

44.11%-0.49

---0.43

---0.39

---0.17

---0.89

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

